One hundred and seventy eight subjects (3.4%) had a serum AAT level below 0.9 g/l, the recommended test limit for further clinical and laboratory investigation of genetic AAT deficiency [17]. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.